Browsing Tag
Regenerative Medicine
33 posts
Could this tiny biotech help fix transplant logistics? LifeNet Health thinks so
LifeNet Health acquires Tissue Testing Technologies to scale cryopreservation in transplants. Find out how this deal reshapes regenerative medicine.
FDA nod sends Organogenesis shares higher as ReNu eyes BLA filing for knee osteoarthritis pain
Find out how Organogenesis’ FDA alignment clears the path for a ReNu BLA filing in knee osteoarthritis pain and why investors are paying attention now.
Biorep achieves first successful independent PRISM system use in islet isolation
Biorep’s PRISM system achieves first independent islet isolation milestone at SNBTS. Discover how it’s shaping the future of lab automation.
From tissue to biologic: AVANCE’s FDA clearance marks a turning point for nerve injury treatment
Axogen gets FDA biologics nod for AVANCE nerve graft, unlocking 12 years of exclusivity. Find out how this reshapes nerve repair in 2026 and beyond.
HMP Global acquires Music City SCALE in aesthetics education expansion
HMP Global acquires Music City SCALE to expand its aesthetics and dermatology education platform. Discover how this reshapes skin health learning in 2025.
RMTG and CELLGENIC unveil pre-loaded peptide pens — the next frontier in regenerative therapy
Find out how RMTG’s CELLGENIC is expanding into device-enabled regenerative therapy with its new peptide-pen line introduced at the Cancún global summit.
NLS Pharmaceutics and Kadimastem merger gains BIRD Foundation boost for breakthrough Type 1 diabetes therapy
Discover how NLS Pharmaceutics and Kadimastem’s merger, backed by renewed BIRD Foundation funding, positions NewCelX to challenge global leaders in diabetes cell therapy.
Pollon Life files for Hong Kong IPO: Is Jack Ma’s stem cell bet about to pay off?
Find out how Pollon Life, backed by Jack Ma’s Yunfeng Capital, is planning a Hong Kong IPO and what it signals for China’s biotech revival.
Polynovo share price surges after FY25 results, but can it overcome its -37% slide?
Polynovo shares jumped 11.79% after FY25 results showed strong global growth. Can this be the turning point investors have been waiting for?
NYB.AI and Pnaseer Inc. partner on AI-driven hair follicle regeneration drug discovery
NYB.AI and Pnaseer Inc. partner on Project Follica to develop AI-powered hair regeneration therapies with targeted nanoparticle delivery. Read the full strategy.